Lichen International (LICN) Liabilities and Shareholders Equity (2021 - 2025)

Lichen International (LICN) has 5 years of Liabilities and Shareholders Equity data on file, last reported at $75.6 million in Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $75.6 million, down 5.34% year-over-year; the trailing twelve-month figure through Dec 2025 was $295.2 million (up 7.68% YoY), and the FY2025 annual result was $75.6 million, down 5.34% from the prior year.
• Liabilities and Shareholders Equity advanced to $75.6 million in Q4 2025 per LICN's latest filing, from $67.2 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $79.8 million in Q4 2024 and troughed at $42.9 million in Q4 2021.
• A 5-year average of $63.3 million and a median of $66.4 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity soared 40.88% in 2023, then decreased 7.42% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $42.9 million in 2021, then increased by 8.34% to $46.5 million in 2022, then soared by 40.88% to $65.5 million in 2023, then increased by 21.81% to $79.8 million in 2024, then declined by 5.34% to $75.6 million in 2025.
• Business Quant data shows LICN's Liabilities and Shareholders Equity at $75.6 million in Q4 2025, $67.2 million in Q2 2025, and $79.8 million in Q4 2024.